NCT05458219 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05458219
Title	A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Innovent Biologics (Suzhou) Co. Ltd.
Indications	pancreatic ductal adenocarcinoma Advanced Solid Tumor gastric adenocarcinoma gastroesophageal junction adenocarcinoma biliary tract cancer
Therapies	Fluorouracil + IBI343 + Leucovorin + Oxaliplatin Fluorouracil + IBI343 + Irinotecan + Leucovorin + Oxaliplatin IBI343
Age Groups:	senior \| adult
Covered Countries	USA \| AUS

NCT05458219
Clinical Trial Detail